Programs that skip those steps are not running a clinical pathway, regardless of how the marketing reads
Aureli, A., Recupero, R., Mariani, M., Manco, M., Carlomagno, F., Bocchini, S., Nicodemo, M., Marchili, M
Serum biomarkers like B12 or methylmalonic acid are not entirely useful in assessing or monitoring clinical improvement, and injection frequency should not be based on biomarker levels
This makes it a valuable tool for managing chronic gastrointestinal conditions and improving overall digestive health
Welche verschiedenen Breiten stehen zur Auswahl
For randomised clinical trials, the Jadad scale ( To complement the Jadad score, the Cochrane Risk of Bias Tool (RoB 2) (Sterne et al., 2019) was also used for RCTs to provide a domain-based qualitative evaluation, assessing risks related to selection, performance, detection, attrition, and reporting